Abstract
rViscumin is a recombinant mistletoe lectin under clinical investigation as new anti-cancer drug. The relationship between oncogene, e.g., HER-2/neu (c-erbB2) receptor activation and tumor cell chemosensitivity, is of considerable importance to better predict the response to chemotherapy. Here, we analyze the cellular and molecular effects of HER-2 expression on rViscumin chemotoxicity in SKOV-3 cells. We show that selective depletion of HER-2 by ribozyme-targeting markedly decreases cellular sensitivity towards rViscumin. These findings are confirmed by treatment with the well-established inhibitory HER-2 antibody trastuzumab (Herceptin). Using clonal ribozyme-transfected cell lines, we establish a 'HER-2 gene dose' dependence of rViscumin cytotoxicity, which is due to differential induction of apoptosis and is not mediated by cell cycle alterations or altered cellular rViscumin binding/internalization. We further demonstrate an rViscumin-mediated, HER-2-dependent down-regulation of bcl-2 and the dose-dependent activation of members of the MAPK family, p42/44, SAPK/JNK, and p38, but not of caspases-3 and -7.
References
Jan 1, 1992·Cytometry·Z DarzynkiewiczF Traganos
May 12, 1989·Science·D J SlamonA Ullrich
Apr 25, 1988·FEBS Letters·Y EndoH Franz
Nov 24, 1995·Science·Z XiaM E Greenberg
Oct 1, 1993·Human Pathology·Y YamanakaM Korc
Oct 1, 1996·Molecular and Cellular Biology·E TzaharY Yarden
Apr 28, 1997·Toxicology Letters·J M WilliamsC M Taylor
Jul 31, 1997·Oncogene·M D PegramD J Slamon
Feb 12, 1998·Gene Therapy·F CzubaykoA Wellstein
Dec 31, 1997·The Journal of Biological Chemistry·H JuhlF Czubayko
Sep 15, 1998·Immunopharmacology and Immunotoxicology·C N BaxevanisM Papamichail
Sep 4, 1999·Invasion & Metastasis·S A Brooks, A J Leathem
Sep 22, 1999·European Journal of Biochemistry·J EckH Lentzen
Oct 3, 1999·European Journal of Biochemistry·J EckH Lentzen
Nov 2, 1999·Biochemical and Biophysical Research Communications·M LangerH Lentzen
Mar 8, 2000·Cancer Letters·U SchumacherU Mengs
Apr 27, 2000·Toxicology·A AignerF Czubayko
May 8, 2000·International Journal of Cancer. Journal International Du Cancer·S S HsiehF Czubayko
Jun 1, 2000·Growth Factors·A AignerA Wellstein
Aug 26, 2000·The Journal of Biological Chemistry·D L PersonsJ C Pelling
Nov 15, 2000·Biochemical Pharmacology·R ParkH T Chung
Mar 15, 2001·The New England Journal of Medicine·D J SlamonL Norton
May 23, 2001·General Pharmacology·M S KimR Park
Jun 28, 2001·Oncogene·Z Huang
Jul 20, 2001·Experimental Cell Research·R SeidmanM Wolfson
Jul 30, 2002·Glycobiology·Johannes MüthingJürgen Eck
Dec 1, 1994·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·J Kleijnen, P Knipschild
Citations
Aug 10, 2010·Cancer Chemotherapy and Pharmacology·Anja FrömbergAchim Aigner
Jul 15, 2006·Human Gene Therapy·Marius GrzelinskiAchim Aigner
Jun 19, 2010·Nucleic Acids Research·Sue Ka-Yee LawPang-Chui Shaw
Nov 25, 2011·Molecular Cancer·Daniel SchulzeAchim Aigner
Mar 5, 2016·Frontiers in Plant Science·Nasser SewelamPeer M Schenk
May 2, 2012·Cancer Letters·Shu-Ping HsuehWon-Bo Wang
Feb 23, 2008·Biochimica Et Biophysica Acta·Jacqueline M LafkyNita J Maihle
Jan 7, 2010·The Journal of Gene Medicine·Sabrina HöbelAchim Aigner
Aug 23, 2005·Biochemical and Biophysical Research Communications·Daniela PintoRui Medeiros
Apr 27, 2013·Journal of Ethnopharmacology·Hsin-Ling YangYou-Cheng Hseu
Apr 13, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heinz ZwierzinaHans Lentzen
Jun 13, 2009·Journal of Experimental & Clinical Cancer Research : CR·Gunver S KienleHelmut Kiene
Jun 30, 2005·International Journal of Cancer. Journal International Du Cancer·Marius GrzelinskiAchim Aigner
Dec 24, 2004·Gene Therapy·B Urban-KleinA Aigner
Mar 16, 2012·Future Medicinal Chemistry·Jason A WilkenNita J Maihle
Mar 8, 2006·World Journal of Gastroenterology : WJG·Guo-Xian GuanXiang-Fu Zhang
Aug 16, 2017·Scientific Reports·You-Cheng HseuHsin-Ling Yang
Sep 18, 2020·Protein and Peptide Letters·Loganayaki PeriyasamySridhar Muthusami
Mar 30, 2010·Journal of Ovarian Research·Jason A WilkenNita J Maihle